In future study, the role of IL-25 in activating antigen-presenting cells may warrant evaluation, especially for revealing and developing the pharmacological basis of IL-25-mediated anti-metastatic activity and the development of cell-based cancer vaccines. The gene discussed is IL25; the disease is cancer.